Benjamin Nacev, MD PHD University of Pittsburgh Dr. Nacev is a laboratory-based physician-scientist with a focus on sarcoma medical oncology and chromatin dysregulation in cancer. He is a faculty member in the Division of Malignant Hematology and Oncology in the Department of Medicine at the University of Pittsburgh and a member of the UPMC Hillman Cancer Center, where he directs a research program focused on studying sarcoma-associated alterations in genes that regulate the epigenome. Dr. Nacev received his MD and PhD degrees from the Johns Hopkins University School of Medicine, where he also completed internal medicine training. He then completed a medical oncology fellowship at Memorial Sloan Kettering Cancer Center and postdoctoral training at The Rockefeller University, studying epigenetics under Prof. C. David Allis. In the fall of 2022, Dr. Nacev joined the faculty at the University of Pittsburgh, where his laboratory is focused on functional epigenetic studies with the goal of improving treatments for sarcoma patients. Dr. Nacev treats adult patients with sarcomas in his medical oncology clinic, an experience that motivates and inspires his laboratory research program.